Organization
Arizona Arthritis & Rheumatology Associates, Phoenix, AZ, United States of America
1 abstract
Abstract
ASSOCIATION BETWEEN CHANGES IN C-REACTIVE PROTEIN AT WEEK 12 AND PATIENT-REPORTED OUTCOMES AT WEEK 24 WITH SARILUMAB THERAPY ACROSS THREE PIVOTAL PHASE 3 STUDIESOrg: Arizona Arthritis & Rheumatology Associates, Phoenix, AZ, United States of America, NYU Langone Health, New York, NY, United States of America, Stanford University, Palo Alto, CA, United States of America, Sarasota Arthritis Research Center, Sarasota, FL, United States of America, Sanofi Genzyme, Cambridge, MA, United States of America,